Yuwen Bao

机构：Nanjing Children's Hospital, Nanjing Medical University

发表论文 16 篇 · 总被引 106 次 · h-index 7

代表论文

• Trends in accessibility of negotiated targeted anti-cancer medicines in Nanjing, China: An interrupted time series analysis (2022 · Frontiers in Public Health · 被引 24)
• Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma (2023 · International Journal of Clinical Pharmacy · 被引 13)
• Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trial (2023 · BMC Pregnancy and Childbirth · 被引 12)
• Cost-effectiveness analysis of toripalimab plus chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer in China (2023 · Frontiers in Immunology · 被引 11)
• Cost-Effectiveness of Pyrotinib Plus Capecitabine versus Lapatinib Plus Capecitabine for the Treatment of HER2-Positive Metastatic Breast Cancer in China: A Scenario Analysis of Health Insurance Coverage (2022 · Current Oncology · 被引 10)
• How National Health Insurance Coverage Policy Affected the Use of Trastuzumab and Rituximab in China: A Bicentric Retrospective Study (2023 · Risk Management and Healthcare Policy · 被引 8)